PROK Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
150.0K
-33.6%
226.0K
+0.4%
225.0K
+3.7%
217.0K
-1.8%
221.0K
Cost of Revenue
0
0
0
0
0
Gross Profit
150.0K
-33.6%
226.0K
+0.4%
225.0K
+3.7%
217.0K
-1.8%
221.0K
Operating Expenses
48.5M
+7.4%
45.2M
-1.0%
45.6M
+17.6%
38.8M
-2.9%
39.9M
R&D
36.1M
+6.7%
33.8M
-0.9%
34.2M
+27.4%
26.8M
+3.6%
25.9M
SG&A
12.4M
+9.8%
11.3M
-1.1%
11.4M
-4.2%
11.9M
-15.0%
14.0M
Operating Income
-48373000
-7.7%
-44933000
+1.0%
-45371000
-17.7%
-38539000
+2.9%
-39709000
EBITDA
-46695000
-7.9%
-43275000
+0.6%
-43534000
-18.1%
-36866000
+3.6%
-38244000
Net Income
-46436000
-9.0%
-42621000
-4.3%
-40852000
-14.0%
-35843000
+3.0%
-36965000
EPS (Basic)
$-0.15
-7.1%
$-0.14
-7.7%
$-0.13
-8.3%
$-0.12
+7.7%
$-0.13
EPS (Diluted)
$-0.15
-7.1%
$-0.14
-7.7%
$-0.13
-8.3%
$-0.12
+7.7%
$-0.13
Shares (Diluted)
186.6M
+31.5%
141.9M
-0.8%
143.1M
+6.0%
135.0M
+3.3%
130.7M
ProKidney (PROK) โ€” Financials